INSIGHTS ON PHARMACEUTICAL PACKAGING

  • Planning For Scale-Up
    5/21/2026

    From rapid early-stage production to scalable commercialization, discover the packaging and continuity challenges companies face as they prepare for launch.

  • Understanding The Regulatory Landscape For Ophthalmic Drug Products
    5/14/2026

    Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.

  • Establishing A Container Closure System
    5/13/2026

    As a trusted partner to both established and emerging drug developers, we support the safe, effective containment and delivery of life-saving and life-enhancing medicines.

  • Start Packaging Development Early
    5/12/2026

    To avoid costly delays later in the product lifecycle, it is essential to plan for key variables early and select container closure systems with confidence from the outset.

PHARMACEUTICAL PACKAGING SOLUTIONS

  • BD Libertas™ Wearable Injector is designed to deliver subcutaneous injections of large volume (2-5 mL or 5-10 mL) and/or high viscosity (up to 50 cP) fixed dose biologics for the non-acute setting.

  • Flexible, scalable capabilities for autoinjectors, pens, and prefilled syringes — ranging from manual to fully automated — streamlining and simplifying your biologic drug development supply chain.

  • How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.

  • We provide a flexible and dynamic approach to GMP manufacturing. From first in human (FIH) through to phase 3 clinical supplies manufacturing at our MHRA Approved and Home Office Approved (I-IV) GMP facility, Trent Gateway.

  • Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.